Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients

BACKGROUND AND OBJECTIVES: Inhibitors of sodium–glucose cotransporter 2 (SGLT2i) reduce the risk of hospitalization for heart failure (HF). We aimed to examine the effect of empagliflozin on change of diuretics dose in outpatient HF patients. METHODS: We retrospectively reviewed the medical records...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo-Jin, Kim, Bong-Joon, Im, Sung-Il, Kim, Hyun-Su, Heo, Jung-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Heart Failure 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634028/
https://www.ncbi.nlm.nih.gov/pubmed/36381017
http://dx.doi.org/10.36628/ijhf.2022.0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634028/
https://www.ncbi.nlm.nih.gov/pubmed/36381017
http://dx.doi.org/10.36628/ijhf.2022.0009

Ejemplares similares